Contract 75N91020F00003
Sri International · Department Of Health And Human Services · September 27, 2020
Sri International was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 27, 2020 for $975.25 million of work in pharmaceutical preparation manufacturing. Performance is in Menlo Park, CA. This is a task or delivery order issued under parent IDIQ HHSN261201700014I. The contract has been modified 11 times since the base award It uses cost-plus contract pricing. The most recent modification was on June 26, 2025.
Contract details
- PIID
- 75N91020F00003
- Parent IDIQ
- HHSN261201700014I
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Special Studies/Analysis- Chemical/Biological
- Place of performance
- Menlo Park, CA
- First action
- September 27, 2020
- Latest action
- June 26, 2025
Description
ANALYSIS FOR NSC 726188 (3 LOTS): APPEARANCE, PROTON NMR, INFRARED, HPLC* (ASSAY, IMPURITY), MOISTURE (KF). POP IS 05/01/2020 - 09/30/2020
Modification timeline
-
June 26, 2025Mod P00001 · Supplemental Agreement For Work Within Scope$37.7K
-
September 6, 2024Mod P00044 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.78B
-
August 31, 2024Mod P00043 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.78B
-
August 27, 2024Mod P00042 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.75B
-
August 13, 2024Mod P00041 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.71B
-
July 19, 2024Mod P00040 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.72B
-
June 26, 2024Mod P00039 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.72B
-
September 28, 2023Mod P00032 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.62B
-
September 28, 2022Mod P00022 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.17B
-
September 28, 2021Mod P00013 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$751.97M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91020F00003?
Contract 75N91020F00003 is a federal contract awarded to Sri International by Department Of Health And Human Services on September 27, 2020 for $975.25 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 11 times since the base award.
Who won contract 75N91020F00003?
Sri International won contract 75N91020F00003 from Department Of Health And Human Services.
How much is contract 75N91020F00003 worth?
Contract 75N91020F00003 has obligated $975.25 million to date.